KRAS and papilloma: Elegant work by the laboratories of Blanpain and colleagues11, and Jensen and colleagues10 have shown when Kras is targeted to skin stem cells, there is long latency to papilloma formation (similar to the BrafV600E allele described here) and most of these lesions form around areas associated with wounding.